An online survey of 3,700 scientists conducted by the American Society for Biochemistry and Molecular Biology (ASBMB) and 15 other scientific organizations in June and July found that cuts in US government research funding has affected research activities. Academic researchers accounted for 91% of respondents, and 81% were faculty or primary investigators. Sixty-three percent of […]
Power continues to shift in the oil industry from major publicly listed oil firms (supermajors) to national oil companies (NOCs). More than 90% of global oil reserves are now owned by NOCs, and six of the world’s largest oil producers are NOCs. As a result, the supermajors are now more dependent on finding fresh sources […]
An analysis of 1,027 human drug targets in active preclinical or clinical projects, excluding multiple-target projects, in Citeline’s 2013 Pharmaproject database has found 58% are being worked on by more than one company. Of the 247 proven targets for which drugs have previously been developed, 88% are being worked on by multiple companies, with four […]
The IVD market experienced the slowest growth of the last decade in 2012. The market grew 4.8% in 2012, according to Enterprise Analysis. The anatomic pathology segment grew the fastest at 8.3%. The molecular and point of care/physician office laboratory segments grew 7.2% and 7.0%, respectively. Despite lackluster growth, the market is expected to rebound […]
In 2012, chemical spending by the world’s top 50 chemical firms fell 1.8% to $961.8 billion, following a 13.7% increase. BASF, Dow Chemical and Sinopec maintained their positions as the largest chemical firms, although the firms’ sales were down 21.7%, 2.1% and 98.6%, respectively. Total operating profits from the 46 firms that reported them fell […]
Although global renewable energy spending grew 17% in 2011, it fell 11% in 2012 to $269 billion. Spending is likely to fall again this year, mostly due to fossil fuel subsidies and regulatory issues, but rebound over the next few years as technology advances and costs decline. The Group of Twenty (G-20) countries comprised 81% […]
As part of the Food Safety Modernization Act, the FDA proposed two rules this month to ensure that foreign suppliers adhere to the same food safety standards as domestic producers. As part of the proposed Foreign Supplier Verification Programs for Importers of Food for Humans and Animals (FSVP), for the first time, importers would be […]
According to the Semiconductor Equipment and Materials Institute’s (SEMI) latest forecast, sales of capital equipment will fall 1.7% this year to $36.29 billion before climbing 21.2% in 2014, led by spending on NAND Flash fabs and investments by Intel. Spending on Test, Assembly & Packaging, and Other equipment is expected to decline 15.5%, 17.2% and […]
Amid an economic slump, capital and R&D spending increased in 2012 for the majority of the 15 US, 16 European and 12 Japanese chemical firms followed by Chemical & Engineering News, indicating confidence in stronger demand ahead. Among these companies, capital spending by the European firms soared 51.8% to $20,512 million and R&D expenditures increased […]
Global primary energy consumption increased 1.8% in 2012, compared with 2.4% in 2011, as a result of improved energy efficiency and the economic downturn. Much of the demand came from non-OECD countries, as China and India combined represented 89% of growth. Oil was the primary fuel used in 2012, with consumption increasing by 890,000 barrels […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
